Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06400095 · ClinicalTrials.gov registry record
Ventilatory Parameters in Predicting Outcomes in ARDS Patients
A clinical trial of ARDS and Mechanical Power, sponsored by CentraCare.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06400095: Recruiting study of ARDS and Mechanical Power, sponsored by CentraCare.
NCT06400095 is a study of ARDS and Mechanical Power that is actively recruiting participants, run by CentraCare. The registered enrollment target is 50 participants, below the 583-participant average among 14 other ARDS trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06400095, a study of ARDS and Mechanical Power, is actively recruiting participants, sponsored by CentraCare.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-centre prospective observational study aimed to determine if Pocc (occlusion pressure at 100 msec), TCe ( Expiratory time constant ), Mechanical Stress power, Ventilatory ratio and C20/Cdyn would predict outcomes in patients with moderately severe ARDS (Acute respiratory distress syndrome), who are on mechanical ventilation
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Poccl, Time constant, driving pressure
Study Locations (1)
Minnesota
- St Cloud Hospital - Saint Cloud
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-07 |
What NCT06400095 shows while recruiting
NCT06400095 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 583-participant average among 14 other ARDS trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with ARDS appearing as the primary indexed condition, and to 1 intervention - of which Poccl, Time constant, driving pressure is the first listed.
NCT06400095 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06400095 about?
NCT06400095 is a clinical study titled "Ventilatory Parameters in Predicting Outcomes in ARDS Patients". This is a single-centre prospective observational study aimed to determine if Pocc (occlusion pressure at 100 msec), TCe ( Expiratory time constant ), Mechanical Stress power, Ventilatory ratio and C20/Cdyn would predict outcomes in patients with moderately severe ARDS (Acute respiratory distress sy...
What is the current status of trial NCT06400095?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2023-06-01. Estimated completion is 2025-07.
What conditions does trial NCT06400095 study?
This clinical trial studies the following conditions: ARDS, Mechanical Power.
What interventions are being tested in trial NCT06400095?
The interventions under investigation include: Poccl, Time constant, driving pressure (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06400095?
This trial is sponsored by CentraCare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06400095 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ARDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06400095's enrollment target sits among peer trials
50 13th of 14 higher than 2 of 14 other ARDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ARDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RECRUITING · Phase 2
-
The APS Phenotyping Study
RECRUITING
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RECRUITING · Phase 2
-
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
RECRUITING · Phase 3
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
RECRUITING · Phase 2
-
Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI